ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

“Withheld” News Release On QRA Policies Released

November 11, 1983

Kansas Gov. Sebelius Nominated For HHS

March 6, 2009

Non-Adherence To Protocol Explains Outcome Differences In Hispanic Children With ALL

December 31, 2010

Fountain Displays Some Statesmanship

July 8, 1977

DRG Reimbursement Schedules Estimated for High, Low Areas; City Of Hope Added to Exemptions, Other Without Much Hope

November 18, 1983

ELM’s CHOP-DS Aims For 15% Of Patients

September 13, 1985